News/November 20, 2026

Research indicates TMEM174 deficiency adversely affects vascular health and lifespan in animal models — Evidence Review

Published in Scientific Reports, by researchers from University of Colorado Anschutz School of Medicine

Researched byConsensus— the AI search engine for science

Table of Contents

New research highlights that a kidney protein, TMEM174, helps regulate blood phosphate levels, and its deficiency can accelerate blood vessel calcification and shorten lifespan, especially in the context of high-phosphate diets. Related studies generally support these findings, showing TMEM174's role in phosphate homeostasis and vascular health, and they further suggest that dietary phosphate is an important modifiable risk factor for cardiovascular disease (University of Colorado Anschutz School of Medicine).

  • The new study's findings align with recent animal research demonstrating that TMEM174 disruption leads to hyperphosphatemia and increased vascular calcification, supporting a causal link between this protein, phosphate regulation, and cardiovascular risk 1 2.
  • Multiple studies reinforce the idea that excess phosphate promotes vascular aging and calcification, particularly in the context of chronic kidney disease, and highlight the importance of dietary management as a potential intervention 1 2 8.
  • Broader vascular aging research supports the concept that molecular disruptions—such as those affecting phosphate handling—can influence arterial stiffness, endothelial dysfunction, and ultimately lifespan, suggesting that TMEM174 may be part of a wider network of longevity regulators 8 9 10 11.

Study Overview and Key Findings

Abnormal phosphate regulation is a well-established risk factor for vascular calcification and cardiovascular disease, particularly in patients with chronic kidney disease (CKD). However, the molecular mechanisms connecting phosphate handling to vascular health and longevity have remained incompletely understood. This study is timely in identifying a new player—TMEM174—in the renal regulation of phosphate and linking its deficiency to accelerated vascular aging in animal models. These findings have potential implications for both basic science and the development of new treatments for CKD-related vascular complications.

Property Value
Study Year 2026
Organization University of Colorado Anschutz School of Medicine
Journal Name Scientific Reports
Authors Jose G. Miranda, Judith Blaine, Makoto Miyazaki
Population Animal models lacking TMEM174
Methods Animal Study
Outcome Phosphate regulation, vascular calcification, lifespan
Results TMEM174 deficiency reduced lifespan and increased vascular calcification.

To contextualize the new findings, we searched the Consensus research database, which indexes over 200 million scientific papers. The following queries were used to identify relevant literature:

  1. TMEM174 deficiency vascular calcification
  2. nutrient effects blood vessel health
  3. lifespan reduction vascular health mechanisms

Below is a summary table of key topics and findings from related studies:

Topic Key Findings
How does TMEM174 influence phosphate regulation and vascular calcification? - TMEM174 directly interacts with NPT2A to regulate phosphate reabsorption in the kidney; its knockout or deficiency leads to elevated blood phosphate and vascular calcification in mice 1 2.
- TMEM174 deficiency exacerbates the harmful effects of high-phosphate diets on vascular tissues, reducing lifespan in animal models 2.
What is the impact of dietary nutrients (phosphate, polyphenols, flavonoids, nuts) on blood vessel health? - Excess dietary phosphate, particularly from additives, can accelerate vascular calcification and aging, especially in the context of impaired kidney function 2 8.
- Polyphenol-rich foods, flavonoids, and nuts may improve vascular function, reduce blood pressure, and provide some protection against cardiovascular disease, but evidence varies and depends on population, dose, and dietary pattern 4 5 6.
What are the mechanisms underlying vascular aging and reduced lifespan? - Vascular aging involves arterial stiffening, endothelial dysfunction, and increased calcification, which are influenced by molecular pathways including phosphate regulation, oxidative stress, and chronic inflammation 8 9 10 11.
- Disruptions in nutrient handling, such as persistent hyperphosphatemia, contribute to accelerated vascular aging and reduced longevity in animal models 2 8 9.
Can targeting molecular pathways (like TMEM174 or related regulators) extend lifespan or improve vascular health? - Modulating proteins involved in phosphate regulation, such as TMEM174, represents a potential therapeutic avenue for reducing vascular calcification and extending lifespan in animal models 2 12.
- Other interventions, such as enhancing VEGF signaling or long-term calorie restriction, also show promise in slowing vascular aging and improving longevity 12 9.

How does TMEM174 influence phosphate regulation and vascular calcification?

Recent animal studies have established TMEM174 as a novel kidney protein that modulates the activity of NPT2A, a key transporter for phosphate reabsorption. Both genetic and experimental disruption of TMEM174 lead to elevated blood phosphate and vascular calcification, providing strong mechanistic support for its protective role against phosphate-induced vascular damage. The new study extends these findings by showing that TMEM174 deficiency, especially when combined with a high-phosphate diet, significantly reduces lifespan in animal models.

  • TMEM174 interacts with NPT2A to limit phosphate reabsorption, safeguarding against hyperphosphatemia and vascular calcification 1 2.
  • Animal models lacking TMEM174 develop higher serum phosphate, increased FGF23 and PTH levels, and more severe vascular calcification 1.
  • High dietary phosphate intake amplifies the detrimental vascular effects in TMEM174-deficient mice, further reducing lifespan 2.
  • These findings consistently position TMEM174 as a potential therapeutic target for phosphate-related vascular pathologies 1 2.

What is the impact of dietary nutrients (phosphate, polyphenols, flavonoids, nuts) on blood vessel health?

Dietary phosphate, especially from highly absorbable additives in processed foods, is increasingly recognized for its potential to accelerate vascular calcification and aging, particularly in individuals with impaired kidney function. At the same time, other nutrients such as polyphenols, flavonoids, and nuts have shown variable but sometimes beneficial effects on vascular health, including improvements in endothelial function and blood pressure regulation.

  • Excess dietary phosphate can promote vascular calcification, especially when phosphate regulation mechanisms are impaired 2 8.
  • Processed foods high in phosphate additives are a notable risk factor, as these forms are more efficiently absorbed than naturally occurring phosphate 2.
  • Polyphenol-rich foods, flavonoids, and nuts may confer vascular benefits, but effects depend on factors such as population, dose, and intervention duration 4 5 6.
  • No single dietary component entirely counteracts vascular risks, highlighting the importance of overall dietary patterns 5 6.

What are the mechanisms underlying vascular aging and reduced lifespan?

Vascular aging encompasses arterial stiffening, endothelial dysfunction, and calcification—processes driven by multiple molecular pathways, including those regulating phosphate, oxidative stress, and inflammation. Persistent disturbances in phosphate metabolism, as seen in TMEM174 deficiency, can exacerbate these age-related vascular changes, ultimately impacting organismal lifespan.

  • Vascular dysfunction and stiffening are independent predictors of cardiovascular disease and reduced health span in older adults 9 10.
  • Disruptions in phosphate handling accelerate vascular aging and can contribute to early mortality, as demonstrated in animal models 2 8 9.
  • Mechanistically, factors such as oxidative stress, inflammation, cellular senescence, and deregulated nutrient sensing play key roles 8 9 11.
  • Long-term interventions—such as calorie restriction—may prevent or delay age-related vascular changes 9.

Beyond dietary adjustments, targeting molecular regulators such as TMEM174 represents a promising strategy for mitigating vascular calcification and improving longevity, at least in preclinical models. Related studies also demonstrate that interventions like enhancing VEGF signaling or calorie restriction can positively influence vascular health and lifespan, suggesting a broader therapeutic potential in targeting aging pathways.

  • Modulation of TMEM174 or its downstream pathways could reduce phosphate-driven vascular calcification and extend lifespan in animal models 2.
  • Enhancing VEGF signaling in aged mice has been shown to improve organ function and extend lifespan, indicating the impact of vascular interventions on healthy aging 12.
  • Long-term calorie restriction prevents arterial stiffening and endothelial dysfunction, supporting the value of systemic interventions 9.
  • The translation of these findings to humans remains an important area for future research 2 12.

Future Research Questions

While the current study advances understanding of TMEM174's role in phosphate regulation and vascular aging, several questions remain. Further research is needed to clarify the relevance of TMEM174 in human populations, the interplay with other nutrient and hormonal regulators, and the potential for new therapies targeting this pathway.

Research Question Relevance
Does TMEM174 deficiency contribute to vascular calcification and reduced lifespan in humans? Understanding whether TMEM174 mutations or expression differences are linked to vascular aging and mortality in humans is critical before considering clinical interventions 1 2.
Can targeting TMEM174 or NPT2A interactions reduce phosphate-driven vascular calcification in chronic kidney disease? Investigating molecular therapies that modulate this pathway could yield new treatment options for CKD patients at high risk of cardiovascular complications 2.
What is the relative impact of dietary phosphate sources (additives vs. natural) on vascular health and aging? Determining the differences in absorption and vascular effects between phosphate additives and naturally occurring phosphate could refine dietary recommendations 2 8.
How do other nutrients (polyphenols, flavonoids, nuts) modify the risk of vascular calcification in the context of high phosphate intake? Exploring interactions between dietary components and phosphate metabolism could help identify protective dietary patterns or interventions 4 5 6.
What are the molecular mechanisms by which TMEM174 regulates NPT2A and phosphate homeostasis? Detailed mechanistic studies will clarify how TMEM174 influences NPT2A function and may uncover additional therapeutic targets for managing phosphate-related vascular complications 1 2.

Sources